Stephen Andrew Welch
CIK 1944355 · EVP & Head of Spec Generics · last filed 2025-11-12
Stephen Andrew Welch is an EVP & Head of Spec Generics who has filed 10 SEC Form 4 insider transactions across 1 company since 2022. Across all open-market trades the lifetime net is +$8.5K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
10
$8.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Keenova Therapeutics plc (MNK) Delisted | EVP & Head of Spec Generics | 32,686 | $0.34 | $11.1K | $8.5K | 5 | 2023-08-18 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-12 | — | Disp (D) | — | $0 | |
| 2025-08-04 | — | Grant (A) | — | $0 | |
| 2025-01-02 | — | Mixed | +3,631 | $0 | |
| 2024-02-06 | — | Grant (A) | — | $0 | |
| 2023-11-16 | — | Disp (D) | −32,686 | $0 | |
| 2023-08-18 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −5,859 | -$4.1K | EDGAR |
| 2023-07-05 | Keenova Therapeutics plc (MNK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-04-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-15 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +1,000 | $8.5K | EDGAR |
| 2022-12-22 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +37,545 | $0 | EDGAR |